2010年1月美国制药行业研究报告

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

【出版时间及名称】：2010年1月美国制药行业研究报告
        【作者】：瑞士信贷
        【文件格式】：PDF
        【页数】：52
        【目录或简介】：
Table of contents
Portfolio Manager’s Summary 3
The Pharmaceutical Sector Should Outperform in 2010 3
Merck and Pfizer Are the Stocks to Own in 2010 5
Fundamentals Improving and Challenges Better Understood 8
Positive Product News Flow Could Improve Sentiment on Sector’s R&D Productivity 8
Focus Moving Away from the Patent Cliff as Companies Become More Diversified 10
Diversification Softens Impact of Pharma Patent Losses 12
Emerging Markets Impact Will Start to Grow 14
Trough Earnings More Visible and Upside Potential Exists 15
Historically, Positive Earnings Revisions Are Met with Outperformance 15
Healthcare Reform, at a Minimum Better Understood 17
Reduced Pricing Power May Be Managed Through Cost Cuts 18
Relative Company Earnings and Sales Compares 19
Low Valuation as the Backdrop 21
Pharma Valuation Still at Historic Lows Since 1988 21
4Q Has Traditionally Been Kind to Healthcare Sector 23
Early 2010 Performance Seems to Indicate Some Rotation from Tech and Consumer
Discretionary 24
New Target Prices Still Imply Multiples Beneath S&P Levels 24
Appendix 28
Company Catalyst Tables 28
Company Revenue Projections and Income Statements 34

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏0 回帖

关键词：行业研究报告 制药行业 研究报告 行业研究 Productivity 美国 研究报告 行业

这是天价啊，明摆着不想卖嘛

脑子进水了，估计你这学科带头人跟中国千千万万的博导一样，只知道剥削博士，自己的学术水平都是蒙骗来的。

zhen bucuo you shijiyou syou yyou 真不错

fcuk.........

too expensive~